Brad Keselowski Gives Update on Status Ahead of COTA Race Brad Keselowski Gives Update on Status Ahead of COTA Race This page ...
Does extending your sleep in the week prior to an upcoming period of sleep deprivation work to keep you more alert?
Q4 2025 earnings call recap: evorpacept/CD47 biomarker data, ASPEN-09 expansion, ALX2004 updates, and $150M raise—read now.
Bayer today announced results from the ongoing global Phase I first-in-human, dose-escalation PAnTHa study (NCT06217822) evaluating the safety, tolerability and preliminary efficacy of ...
Today, we released our definitive fourth quarter financial results, which include adjusted EBITDA of $28,500,000 and 3,800,000 tons shipped. This closes out a year that presented a number of ...
Reports net loss of $17.3 million for the fourth quarter 2025 Posts Adjusted EBITDA of $28.5 million for the quarter BRISTOL, Tenn., Feb. 27, 2026 /PRNewswire/ ...
Q4 2025 Earnings Call February 27, 2026 4:00 AM ESTCompany ParticipantsJarle Dragvik - Chief Executive OfficerMartin Holtet - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results